# FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients

> **NCT07385599** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Lifetech Scientific (Shenzhen) Co., Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Non-valvular Atrial Fibrillation (NVAF)

## Interventions

- **DEVICE:** LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System

## Key facts

- **NCT ID:** NCT07385599
- **Lead sponsor:** Lifetech Scientific (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-01-19
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-03-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07385599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07385599, "FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07385599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*